These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 6244003)

  • 1. Kinetics of the hormone-receptor interaction. Competition experiments with slowly equilibrating ligands.
    Arányi P
    Biochim Biophys Acta; 1980 Mar; 628(2):220-7. PubMed ID: 6244003
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The kinetics of competitive radioligand binding predicted by the law of mass action.
    Motulsky HJ; Mahan LC
    Mol Pharmacol; 1984 Jan; 25(1):1-9. PubMed ID: 6708928
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Kinetics of the glucocorticoid hormone-receptor interaction. False association constants determined in slowly equilibrating systems.
    Arányi P
    Biochim Biophys Acta; 1979 May; 584(3):529-37. PubMed ID: 454679
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Requirements for reliable determination of binding affinity constants by kinetic approach.
    Borgna JL
    J Steroid Biochem Mol Biol; 2005 Jul; 96(2):141-53. PubMed ID: 15925507
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Kinetic identification of a two-state glucagon receptor system in isolated hepatocytes. Interconversion of homogeneous receptors.
    Horwitz EM; Jenkins WT; Hoosein NM; Gurd RS
    J Biol Chem; 1985 Aug; 260(16):9307-15. PubMed ID: 2991239
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Investigating the Influence of Tracer Kinetics on Competition-Kinetic Association Binding Assays: Identifying the Optimal Conditions for Assessing the Kinetics of Low-Affinity Compounds.
    Sykes DA; Jain P; Charlton SJ
    Mol Pharmacol; 2019 Sep; 96(3):378-392. PubMed ID: 31436538
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Kinetic behavior of slowly equilibrating association-dissociation enzyme systems].
    Kurganov BI; Dorozhko AI; Kagan ZS; Iakovlev VA
    Mol Biol (Mosk); 1975; 9(4):533-42. PubMed ID: 1214796
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Kinetics of nonpeptide antagonist binding to the human gonadotropin-releasing hormone receptor: Implications for structure-activity relationships and insurmountable antagonism.
    Sullivan SK; Hoare SR; Fleck BA; Zhu YF; Heise CE; Struthers RS; Crowe PD
    Biochem Pharmacol; 2006 Sep; 72(7):838-49. PubMed ID: 16930559
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dual-point competition association assay: a fast and high-throughput kinetic screening method for assessing ligand-receptor binding kinetics.
    Guo D; van Dorp EJ; Mulder-Krieger T; van Veldhoven JP; Brussee J; Ijzerman AP; Heitman LH
    J Biomol Screen; 2013 Mar; 18(3):309-20. PubMed ID: 23093571
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Analysis of receptor binding displacement curves by a nonhomologous ligand, on the basis of an equivalent competition principle.
    van Zoelen EJ
    Anal Biochem; 1992 Feb; 200(2):393-9. PubMed ID: 1321566
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A computerized approach towards the estimation of binding parameters to characterize cooperative and non-cooperative multicomponent ligand-receptor interactions.
    Quednau HD; Rao ML
    Int J Biomed Comput; 1985 Mar; 16(2):135-42. PubMed ID: 2995257
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Competitive binding kinetics in ligand-receptor-competitor systems. Rate parameters for unlabeled ligands for the formyl peptide receptor.
    Sklar LA; Sayre J; McNeil VM; Finney DA
    Mol Pharmacol; 1985 Oct; 28(4):323-30. PubMed ID: 4058418
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Determination of receptor protein binding site specificity and relative binding strength using a time-resolved competition assay.
    Barta P; Volkova M; Dascalu A; Spiegelberg D; Trejtnar F; Andersson K
    J Pharmacol Toxicol Methods; 2014; 70(2):145-51. PubMed ID: 25084055
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Autocrine ligand binding to cell receptors. Mathematical analysis of competition by solution "decoys".
    Forsten KE; Lauffenburger DA
    Biophys J; 1992 Feb; 61(2):518-29. PubMed ID: 1312367
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development and Characterization of a Fluorescent Tracer for the Free Fatty Acid Receptor 2 (FFA2/GPR43).
    Hansen AH; Sergeev E; Pandey SK; Hudson BD; Christiansen E; Milligan G; Ulven T
    J Med Chem; 2017 Jul; 60(13):5638-5645. PubMed ID: 28570808
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Suramin is a slowly-equilibrating but competitive antagonist at P2x-receptors in the rabbit isolated ear artery.
    Leff P; Wood BE; O'Connor SE
    Br J Pharmacol; 1990 Nov; 101(3):645-9. PubMed ID: 2076483
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Real-time competitive kinetic analysis of interactions between low-molecular-weight ligands in solution and surface-immobilized receptors.
    Karlsson R
    Anal Biochem; 1994 Aug; 221(1):142-51. PubMed ID: 7985785
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Studies on the irreversible nature of prolactin binding to receptors.
    van der Gugten AA; Waters MJ; Murthy GS; Friesen HG
    Endocrinology; 1980 Jan; 106(1):402-11. PubMed ID: 6243100
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Investigation of the competition of two ligands for the same binding sites on a protein.
    Lecureuil N; Trochet J; Garreau L; Crouzat-Reynes G; Lecureuil M
    Anal Biochem; 1986 Dec; 159(2):396-401. PubMed ID: 3826624
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Estimation of the affinities of allosteric ligands using radioligand binding and pharmacological null methods.
    Ehlert FJ
    Mol Pharmacol; 1988 Feb; 33(2):187-94. PubMed ID: 2828914
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.